Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

scientific article published on September 1999

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ.BJC.6690669
P932PMC publication ID2374363
P698PubMed publication ID10487631
P5875ResearchGate publication ID12811846

P50authorShan Wang-GohrkerQ30831711
Steven A. NarodQ50384888
P2093author name stringWeber B
Kieback DG
Lerman C
Kreienberg R
Runnebaum IB
Stickeler E
Brunet JS
Abrahamson J
Weikel W
Risch H
Moslehi R
Godwin A
Vesprini D
Olipade O
P2860cites workP53 polymorphisms and haplotypes in lung cancerQ71730111
p53 polymorphism in ovarian and bladder cancerQ71852144
Absence of Significant Germ Line p53 Mutations in Ovarian Cancer PatientsQ72053821
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancerQ72152728
Identification of a polymorphism in intron 2 of the p53 geneQ72387836
p53 germline polymorphisms are associated with an increased risk for breast cancer in German womenQ74806768
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage ConsortiumQ29619206
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi JewsQ29619407
Biallelic Apal polymorphism of the human p53 gene (TP53)Q35781509
An intron binding protein is required for transformation ability of p53.Q40506598
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated reviewQ40901949
Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell linesQ41607935
Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypesQ41946290
TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.Q42858445
Polymorphisms in the p53 gene in thyroid tumours and blood samples of children from areas in BelarusQ44475644
Analysis of intron 4 of the p53 gene in human cutaneous melanomaQ48058889
HaeIII polymorphism in intron 1 of the human p53 geneQ48085364
A novel germ line p53 mutation in intron 6 in diverse childhood malignanciesQ48730972
p53 polymorphisms and haplotypes in breast cancer.Q53454066
P53 germ line haplotypes associated with increased risk for colorectal cancer.Q53462888
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locusQ59548827
Tissue-specific expression of p53 in transgenic mice is regulated by intron sequencesQ67914619
Hereditary ovarian cancer. Heterogeneity in age at diagnosisQ68189618
Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 geneQ70598718
Simple sequence repeat polymorphism within the p53 geneQ70738656
A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibilityQ70818297
p53 polymorphism in ovarian and breast cancerQ70994813
p53 polymorphisms and haplotypes in nasopharyngeal cancerQ71576479
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
P304page(s)179-183
P577publication date1999-09-01
P1433published inBritish Journal of CancerQ326309
P1476titleIntron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
P478volume81